← Insider buys
SUPN

Supernus Pharmaceuticals, Inc. · Healthcare

Director Georges Gemayel sold $392K of Supernus Pharmaceuticals, Inc.

Sold$391,568
$36.30Price
10,787Shares
−45%Stake

What SUPN did after the filing

Prices for SUPN after this filing aren't in yet.

Traded Fri, Nov 8. Filed Tue, Nov 12, 11:13 AM ET, during the session. Not investment advice.